HORSKÁ, Kateřina, Jan KUČERA, Eva DRAŽANOVÁ, Gabriela KUZMÍNOVÁ, Petra AMCHOVÁ, Mária HRICKOVÁ, Jana RUDÁ and Silje SKREDE. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model. Biomedicine and Pharmacotherapy. ISSY-LES-MOULINEAUX: Elsevier, 2024, vol. 176, July 2024, p. 1-11. ISSN 0753-3322. Available from: https://dx.doi.org/10.1016/j.biopha.2024.116763. |
Other formats:
BibTeX
LaTeX
RIS
@article{2405317, author = {Horská, Kateřina and Kučera, Jan and Dražanová, Eva and Kuzmínová, Gabriela and Amchová, Petra and Hricková, Mária and Rudá, Jana and Skrede, Silje}, article_location = {ISSY-LES-MOULINEAUX}, article_number = {July 2024}, doi = {http://dx.doi.org/10.1016/j.biopha.2024.116763}, keywords = {Antipsychotic; Olanzapine; metabolic adverse effects; GLP-1 receptor agonist; Schizophrenia}, language = {eng}, issn = {0753-3322}, journal = {Biomedicine and Pharmacotherapy}, title = {Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model}, url = {https://www.sciencedirect.com/science/article/pii/S0753332224006474}, volume = {176}, year = {2024} }
TY - JOUR ID - 2405317 AU - Horská, Kateřina - Kučera, Jan - Dražanová, Eva - Kuzmínová, Gabriela - Amchová, Petra - Hricková, Mária - Rudá, Jana - Skrede, Silje PY - 2024 TI - Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model JF - Biomedicine and Pharmacotherapy VL - 176 IS - July 2024 SP - 1-11 EP - 1-11 PB - Elsevier SN - 07533322 KW - Antipsychotic KW - Olanzapine KW - metabolic adverse effects KW - GLP-1 receptor agonist KW - Schizophrenia UR - https://www.sciencedirect.com/science/article/pii/S0753332224006474 N2 - A combined strategy of dulaglutide and food restriction manifested a massive synergistic benefit. GLP-1RAs represent a promising strategy and deserve thorough future research. Our findings underline the potential importance of lifestyle intervention in addition to GLP-1 RA treatment. ER -
HORSKÁ, Kateřina, Jan KUČERA, Eva DRAŽANOVÁ, Gabriela KUZMÍNOVÁ, Petra AMCHOVÁ, Mária HRICKOVÁ, Jana RUDÁ and Silje SKREDE. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model. \textit{Biomedicine and Pharmacotherapy}. ISSY-LES-MOULINEAUX: Elsevier, 2024, vol.~176, July 2024, p.~1-11. ISSN~0753-3322. Available from: https://dx.doi.org/10.1016/j.biopha.2024.116763.
|